Does TOCILIZUMAB Cause Maternal exposure timing unspecified? 327 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 327 reports of Maternal exposure timing unspecified have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.3% of all adverse event reports for TOCILIZUMAB.
327
Reports of Maternal exposure timing unspecified with TOCILIZUMAB
0.3%
of all TOCILIZUMAB reports
208
Deaths
234
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From TOCILIZUMAB?
Of the 327 reports, 208 (63.6%) resulted in death, 234 (71.6%) required hospitalization, and 201 (61.5%) were considered life-threatening.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 327 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
OXYCODONE (300)
Which TOCILIZUMAB Alternatives Have Lower Maternal exposure timing unspecified Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE